Stay updated with breaking news from Franzb humer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) Director Franz B. Humer sold 11,200 shares of the company’s stock in a transaction that occurred on Thursday, May 30th. The stock was sold at an average price of $2.34, for a total value of $26,208.00. Following the completion of the sale, the director now owns 255,253 […] ....
February 14, 2023—Cydar Medical, a global cloud-based software company, announced the appointment of Kenneth Hitchner as Chairman of the Board w ....